Agilent Technologies Inc (NYSE:A)
February 13th, 2019
Amidst rising markets Agilent Technologies Inc finished up $0.16 Wednesday, up 0.21%, closing at $77.25. With an estimated seven days to the next earnings report, everyone is watching Agilent Technologies Inc. Furthermore it hit a new 52 week high of $77.49.
Agilent Technologies Inc is listed on the S&P 500 index, and was one of 328 stocks that increased today. Weighted by market cap, A represents about 0.10% of the S&P 500.
Forecasts from 13 analysts points to the possibility that Agilent Technologies Inc could grow somewhat (1.74%), while Finbox has calculated (with low uncertainty) a fair value price of $65.49.
The market sectors were mixed Wednesday with a majority of the sectors trending up. Energy saw the biggest increase of the day (1.29%), while Utilities saw the biggest drop (-0.31%). Industrials has seen the biggest year-to-date gain at 15.68%.
Energy saw the biggest turnaround from its 5-day performance of -1.99%, as it went up 1.29%. Utilities saw a turn around from its 5-day performance of 1.76% trading down -0.31%.
- Energy went up with a 1.29% change.
- Industrials went up with a 0.63% change.
- Consumer Discretionary went up with a 0.62% change.
- Real Estate went up with a 0.58% change.
- Consumer Staples went up with a 0.25% change.
- Healthcare went up with a 0.25% change.
- Financials went up with a 0.20% change.
- Information Technology went up with a 0.14% change.
- Materials went up with a 0.10% change.
- Communication Services went down with a -0.10% change.
- Utilities went down with a -0.31% change.
Agilent Technologies Inc Info
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies. The Diagnostics and Genomics segment provides reagents, instruments, software, and consumables; arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, and gene expression profiling, as well as sequencing target enrichment, genetic data management, and interpretation support software; and equipment focused on production of synthesized oligonucleotides for use as active pharmaceutical ingredients. The Agilent CrossLab segment offers GC and LC columns, sample preparation products, custom chemistries, and various laboratory instrument supplies; and startup, operational, training, compliance support, and software as a service, as well as asset management and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer’s representatives, and electronic commerce. Agilent Technologies, Inc. was founded in 1999 and is headquartered in Santa Clara, California.
All amounts in USD unless otherwise indicated
Media Gazelle Inc (MG), a Nevada Corporation, owns and operates the online brand US Tribune News. MG does not offer financial advise, and is not a registered broker/dealer/analyst/adviser, holds no investment licenses, and may not sell, offer to sell or offer to buy any security. MG’s market updates, news are not a solicitation or recommendation to buy, sell or hold securities. MG shall not be held liable for any investment losses you may incur by using the information provided, this includes you trading the stocks mentioned on our sites. We recommend you talk to a financial adviser before trading any securities or taking any action based upon information on this site. MG does not guarantee the accuracy of the article.